Clinical Trials on Generic Formulation Interchangeability in Germany

Total 12541 results

University of Hohenheim
German Federal Ministry of Education and Research

Completed

Oral Bioavailability of Curcumin From Micronized Powder and Liquid Micelles in Healthy Young Women and Men

Pharmacokinetics of Novel Curcumin Formulations | Safety of Novel Curcumin Formulations

Germany
University of Hohenheim
German Federal Ministry of Education and Research

Completed

Improved Oral Bioavailability of Curcumin Incorporated Into Micelles

Pharmacokinetics of New Curcumin Formulations | Safety of New Curcumin Formulations

Germany
LTS Lohmann Therapie-Systeme AG

Completed

Magnetic Marker Monitoring of Furosemide-containing Gastroretentive Formulation in Healthy Male Subjects (Fasting and Fed Conditions)

Gastroretentive Drug Formulation of Furosemide | Oedema

Germany
Johann Wolfgang Goethe University Hospital

Completed

Effect of New Oral Anticoagulants Dabigatran and Rivaroxaban on Point of Care Coagulation Testing - an Ex-Vivo Study

Clot Formation and Platelet Aggregation in Point of Care Testing

Germany
Schülke & Mayr GmbH

Completed

Study to Assess the Inhibition of Plaque Formation in Subjects With a Gingival Index ≤1.5

Inhibition of Plaque Formation (by Gingivitis-Index ≤1.5)

Germany
Schülke & Mayr GmbH

Completed

Study to Assess the Inhibition of Plaque Formation in Subjects With a Gingival Index ≤1.5

Inhibition of Plaque Formation (by Gingivitis-Index ≤1.5)

Austria, Germany
Cytokinetics

Completed

COSMIC-HF - Chronic Oral Study of Myosin Activation to Increase Contractility in Heart Failure (COSMIC-HF)

Chronic Heart Failure | Pharmacokinetics | Left Ventricular Systolic Dysfunction | Left Ventricular Ejection Fraction | Modified Release Oral Formulation | History of Chronic Heart Failure | Echocardiogram

United States, Canada, Italy, Netherlands, United Kingdom, Belgium, Czechia, Australia, Hungary, Poland, Bulgaria, Lithuania, Germany
Karoline Krause
Roche Pharma AG

Completed

Tocilizumab in Patients With Schnitzler's Syndrome (TOCISCH)

Schnitzler's Syndrome

Germany
Boston Scientific Corporation

Completed

Registry on WATCHMAN Outcomes in Real-Life Utilization (EWOLUTION)

Patients With Atrial Fibrillation at Risk for Thrombus Formation, Thromboembolism, Stroke

Ireland, Spain, Germany, Netherlands, France, United Kingdom, Italy, Russian Federation, Portugal, Belgium, Poland, Saudi Arabia, United Arab Emirates
University Hospital Tuebingen
Charite University, Berlin, Germany; RWTH Aachen University; Medical University...

Not yet recruiting

Initiative for Clinical Long-read Sequencing (IonGER)

Genetic Predisposition

Germany
University Hospital Tuebingen

Completed

Whole Genome Trio Sequencing as a Standard Routine Test in Patients With Rare Diseases - "GENOME FIRST APPROACH"

Rare Diseases | Genetic Predisposition

Germany
University Hospital Tuebingen

Recruiting

Diagnostic Research in Patients With Rare Diseases - Solving the Unsolved Rare Diseases (DiRiP-RD)

Rare Diseases | Genetic Predisposition

Germany
University Hospital Tuebingen

Recruiting

Diagnostic Value of Exome/ Genome Sequencing, Conventional Methods in Rare Diseases and Familial Tumor Syndromes (EXGEFATU)

Rare Diseases | Genetic Predisposition

Germany
University Hospital Tuebingen

Recruiting

Mitochondrial Diseases - Long-read Genome and Transcriptome Sequencing in Cases Unresolved After Short-read Genomics

Rare Diseases | Genetic Predisposition

Germany
University Hospital Tuebingen

Recruiting

Genome-based Management of Patients in Precision Medicine (Ge-Med) Towards a Genomic Health Program (GE-MED)

Genetic Predisposition to Disease | Rare Diseases

Germany
University Hospital Tuebingen

Recruiting

Genetic Causes of Discrepant Clinic in Monogenic Twins (DISCO-TWIN)

Genetic Predisposition to Disease | Rare Diseases

Germany
University Hospital Tuebingen

Recruiting

Identification of the Genetic Causes of Rare Diseases With Negative Exome Findings

Genetic Predisposition to Disease | Rare Diseases

Germany
Dr. August Wolff GmbH & Co. KG Arzneimittel
SIT Skin Investigation and Technology Hamburg GmbH

Completed

In-Use Test With a Cosmetic Product

Dermatitis, Atopic

Germany
Novartis

Completed

Reconstitution With Pimecrolimus Cream 1% of Steroid-damaged Skin in Adults With Atopic Dermatitis

Atopic Dermatitis

Germany
Bionorica SE

Completed

Assessment of Skin Tolerance and Efficacy of a Cosmetic Product After 4 Weeks of Use on Subjects With Atopic Dermatitis

Eczema-Prone Skin | Atopic Diathesis

Germany
University Hospital Schleswig-Holstein

Recruiting

Disease Trajectories and Anti-cytokine Response Signatures in Atopic Dermatitis and Psoriasis (DiTrAP)

Healthy | Psoriasis | Atopic Dermatitis

Germany
Charite University, Berlin, Germany
Shire International GmbH

Active, not recruiting

Lanadelumab in FXII-associated Cold Autoinflammatory Syndrome (FACAS) (LANA-FXII)

Hereditary Autoinflammatory Disease

Germany
University Hospital Tuebingen

Recruiting

Comparative Genetic and Immune Response Analysis of Different COVID-19 Vaccine Candidates Using Multi-OMICS Approach (COVID 19-VAC)

Genetic Predisposition

Germany
Johann Wolfgang Goethe University Hospital
German Federal Ministry of Education and Research

Unknown

Gene Therapy for Chronic Granulomatous Disease (CGD)

Granulomatous Disease, Chronic

Germany
Goethe University

Completed

Cytokines in Papillon-Lefèvre Syndrome

Papillon-Lefevre Disease

Germany
Clinuvel Europe Limited

Recruiting

A Study to Evaluate the Safety and Efficacy of Afamelanotide in Patients With Xeroderma Pigmentosum (XP)

Xeroderma Pigmentosum

Germany
Novartis Pharmaceuticals

Terminated

EXPLAIN -FragilE X Registry: An exPlorative Longitudinal Study for chAracterIzation, Treatment Pathways and patieNt-related Outcomes (EXPLAIN)

Fragile-X Syndrome

Germany
Augenklinik LMU

Completed

Effect of Compression Dressing After Upper Eyelid Blepharoplasty on Edema, Ecchymosis, Pain and Ocular Surface Irritation

Dermatochalasis of Eyelid

Germany
Technische Universität Dresden

Unknown

Body-fluid Balance and Drinking Habits in Patients With Retinal Vascular Occlusion

Dehydration | Retinal Vascular Occlusion

Germany
Pascoe Pharmazeutische Praeparate GmbH

Completed

PASCONAL NERVENTROPFEN in the Treatment of Nervous Diseases (174)

Sleep Disorders | Nervousness

Germany
Charite University, Berlin, Germany
German Federal Ministry of Education and Research

Completed

Mutation Exploration in Non-acquired, Genetic Disorders and Its Impact on Health Economy and Life Quality (MENDEL)

Genetic Diseases

Germany
Margitta Worm
University of Hamburg-Eppendorf

Completed

Placebo Effect in the Treatment of Atopic Dermatitis

Atopic Dermatitis

Germany
National Institute of Allergy and Infectious Diseases...
Atopic Dermatitis and Vaccinia Network

Completed

Identifying Risk Factors for Eczema Herpeticum in Individuals With Atopic Dermatitis

Atopic Dermatitis | Eczema Herpeticum

Germany
University of Erlangen-Nürnberg Medical School

Completed

Non-invasive Imaging of Muscle Structure in Duchenne Muscular Dystrophy Using Multispectral Optoacoustic Tomography (MSOT_DMD)

Muscular Dystrophies | Duchenne Muscular Dystrophy | Muscular Dystrophy, Duchenne

Germany
University Hospital Tuebingen

Completed

Stargardt Disease in Childhood

Stargardt Disease

Germany
University Hospital Erlangen

Completed

Pediatric SARS-CoV-2 Infections: Course of COVID-19, Immune Responses, Complications and Long-term Consequences (PEDCOVID-19)

Hypohidrotic Ectodermal Dysplasia

Germany
Ludwig-Maximilians - University of Munich

Completed

Deflazacort in Dysferlinopathies

Dysferlinopathy | Miyoshi Myopathy | LGMD2B

Germany
Pari Pharma GmbH

Completed

Bioequivalence and Safety of Vantobra and TOBI in Healthy Subjects

Cystic Fibrosis

Germany
AlgiPharma AS
Imperial College London; Cystic Fibrosis Foundation; University Hospital of Cologne and other collaborators

Withdrawn

A Dose-finding Study of Inhaled OligoG vs Placebo in Patients With Cystic Fibrosis (SMR3372)

Cystic Fibrosis

Germany
Charite University, Berlin, Germany

Completed

Sunphenon Epigallocatechin-Gallate (EGCg) in Duchenne Muscular Dystrophy (SUNIMUD)

Duchenne Muscular Dystrophy

Germany
University Hospital Muenster
German Society of Craniomandibular Function and Disorders in the DGZMK.

Recruiting

TMD-specific Physiotherapy in hEDS Patients Individuals With Hypermobile Ehlers-Danlos Syndrome

Hypermobile Ehlers-Danlos Syndrome

Germany
AstraZeneca
Parexel

Completed

A Study to Compare if the Uptake of Ticagrelor in the Body Differs When Different Tablets Are Administered

Sickle Cell Disease

Germany
University of Cologne

Completed

Whole Body Vibration - a New Therapeutic Approach to Improve Muscle Function in CF

Cystic Fibrosis

Germany
University Hospital, Bonn
Novartis

Completed

Ranibizumab to Treat Choroidal Neovascularization (CNV) in Patients With Pseudoxanthoma Elasticum (PXE)

Choroidal Neovascularization

Germany
University Hospital, Bonn

Completed

Intravitreal Aflibercept for Therapy of Patients With Pseudoxanthoma Elasticum (PXE) (EyNeP)

Pseudoxanthoma Elasticum

Germany
University Hospital Tuebingen

Completed

Interferon-alpha2a Versus Cyclosporin A for Severe Ocular Behcet's Disease (INCYTOB) (INCYTOB)

Panuveitis | Posterior Uveitis | Retinal Vasculitis | Behcet's Disease

Germany
University Hospital Erlangen
Pervormance GmbH

Completed

Short Term Effects and Risks of Physical Exercise in Subjects With Hypohidrotic Ectodermal Dysplasia

X-Linked Hypohidrotic Ectodermal Dysplasia | Exercise-induced Rise of Body Temperature

Germany
German Cancer Research Center
Mukoviszidose Institut gGmbH; Heidelberg University

Completed

Magnetic Resonance Imaging (MRI) for Early Diagnosis of Cystic Fibrosis (CF)

Cystic Fibrosis | Lung Disease

Germany
University Hospital of Cologne

Recruiting

Characterization of Antibacterial Antibodies in Patients With Cystic Fibrosis

Pulmonary Cystic Fibrosis | Neutralizing Antibodies

Germany
Mukoviszidose Institut gGmbH
Hannover Medical School; Goethe University; Federal Ministry of Health, Germany; Wuerzburg University Hospital and other collaborators

Completed

Effects of a Comprehensive Patient-centered Health Service in Cystic Fibrosis (VEMSE-CF) (VEMSE-CF)

Cystic Fibrosis

Germany

Clinical Trials on Generic Formulation Interchangeability in Germany

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Panama

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations